AbbVie, Inc. in BPCIA litigation against Amgen and Boehringer Ingelheim for HUMIRA® (adalimumab injection).*
Akebia Therapeutics Inc. in Hatch-Waxman litigation for AURYXIA® (ferric citrate tablets).*
Alcon Inc. in Hatch-Waxman litigation for SIMBRINZA® (brinzolamide/brimonidine ophthalmic suspension).
Becton, Dickinson, and Co. in Federal Circuit appeal of IPRs filed on telepharmacy systems, resulted in favorable reversal of PTAB decision that challenged claims were obvious.*
Bristol-Myers Squibb Co. and Pfizer Inc. in Hatch-Waxman litigation against 25 generic companies for ELIQUIS® (apixaban tablets).*
EPI Health, LLC in Hatch-Waxman litigation for RHOFADE® (oxymetazoline HCl cream).*
Exelixis Inc. in Hatch-Waxman litigation against MSN for CABOMETYX® (cabozantinib tablets).*
General Electric Co., defending against allegations of patent infringement for offshore wind turbine technology, included first-chairing inequitable conduct portion of case that was separately tried to the bench.*
ModernaTx, Inc. in Federal Circuit appeals of IPRs filed against Arbutus patents related to lipid nanoparticle technology.*
The Trustees of the University of Pennsylvania in patent infringement litigation for a composition of matter and method of treatment patent.
Quest Diagnostics defending against allegations of patent infringement directed to prenatal testing.*
Wonderland Switzerland AG in patent litigation for baby car seats, included presenting corporate witness at trial that resulted in permanent injunction being granted in Wonderland’s favor.
*Experience prior to joining A&O Shearman.